Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 25, 2020 Off

Real World Evidence in Pharma: Quantzig Examines the Top Five Use Cases

By BusinessWire

LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has…

March 25, 2020 Off

Real World Evidence in Pharma: Quantzig Examines the Top Five Use Cases

By BusinessWire

LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has…

March 25, 2020 Off

Why Biopharmaceutical Contract Manufacturing Firms Can’t Afford to Ignore Market Monitoring Solution | Find Out in This Success Story

By BusinessWire

LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on…

March 25, 2020 Off

Why Biopharmaceutical Contract Manufacturing Firms Can’t Afford to Ignore Market Monitoring Solution | Find Out in This Success Story

By BusinessWire

LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on…

March 25, 2020 Off

Recursion Appoints Dr. Michael Secora as Chief Financial Officer

By BusinessWire

Biopharma and technology investing expert to support Recursion’s strategic finance initiatives as it builds the leading digital biology company SALT…

March 25, 2020 Off

Recursion Appoints Dr. Michael Secora as Chief Financial Officer

By BusinessWire

Biopharma and technology investing expert to support Recursion’s strategic finance initiatives as it builds the leading digital biology company SALT…

March 25, 2020 Off

Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund

By BusinessWire

T1D Fund’s investment to advance Repertoire’s platform for innovative cures to treat Type 1 Diabetes CAMBRIDGE, Mass. & BOSTON–(BUSINESS WIRE)–Repertoire…

March 25, 2020 Off

Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund

By BusinessWire

T1D Fund’s investment to advance Repertoire’s platform for innovative cures to treat Type 1 Diabetes CAMBRIDGE, Mass. & BOSTON–(BUSINESS WIRE)–Repertoire…

N4 Pharma tests Nuvec use for developing Covid-19 vaccines with partners
March 25, 2020 Off

N4 Pharma tests Nuvec use for developing Covid-19 vaccines with partners

By Dino Mustafić

N4 Pharma will test a Covid-19 DNA plasmid if Nuvec, a novel delivery system for cancer treatments and vaccines, can be used as a delivery system by potential collaboration partners developing Covid-19 DNA or RNA vaccines.

March 25, 2020 Off

Ohana Biosciences Announces Appointment of David Sable, M.D., to Board of Directors

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ohana Biosciences, a clinical-stage biotechnology company pioneering reproductive health through the industry’s first sperm biology platform, today announced…

Posts pagination

Previous 1 … 4,719 4,720 4,721 … 5,889 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

June 17, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine